tiprankstipranks
Revolution Medicines (RVMD)
NASDAQ:RVMD
US Market
RVMD
Revolution Medicines
RESEARCH TOOLSreports

Revolution Medicines (RVMD) Stock News & Sentiment

639 Followers
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
Premium
Company Announcements
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
12d ago
RVMD
SMMT
Daraxonrasib Poised to Become Pancreatic Cancer Standard of Care on Strong RASolute 302 Outlook and Accelerated Launch Path
Premium
Ratings
Daraxonrasib Poised to Become Pancreatic Cancer Standard of Care on Strong RASolute 302 Outlook and Accelerated Launch Path
1M ago
RVMD
Revolution Medicines Doubles Down on Costly RAS Push
Premium
Company Announcements
Revolution Medicines Doubles Down on Costly RAS Push
1M ago
RVMD
Revolution Medicines: Advancing RAS Inhibitor Pipeline and Strong Cash Runway Support Buy Rating
Premium
Ratings
Revolution Medicines: Advancing RAS Inhibitor Pipeline and Strong Cash Runway Support Buy Rating
1M ago
RVMD
Is RVMD a Buy, Before Earnings?
Premium
Pre-Earnings
Is RVMD a Buy, Before Earnings?
2M ago
RVMD
Revolution Medicines: Differentiated RAS(ON) Pipeline Underpins Overweight/Buy Rating and $92 December 2026 Target
Premium
Ratings
Revolution Medicines: Differentiated RAS(ON) Pipeline Underpins Overweight/Buy Rating and $92 December 2026 Target
2M ago
RVMD
Revolution Medicines Advances RMC-5127 KRAS Program, Extending Its Oncology Reach
Premium
Company Announcements
Revolution Medicines Advances RMC-5127 KRAS Program, Extending Its Oncology Reach
3M ago
RVMD
More RVMD News >

RVMD News on the Web

Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer
CNBC
Bullish
Revolution Medicines (RVMD) Gets a Buy from RBC Capital
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Compugen (CGEN), Revolution Medicines (RVMD)
TipRanks News
Bullish
LifeSci Capital Sticks to Its Buy Rating for Revolution Medicines (RVMD)
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Nuo Therapeutics (AURX)
TipRanks News
Bullish
Revolution Medicines begins treating patients in RASolute 303
TipRanks News
Bullish
Revolution Medicines (RVMD) Gets a Buy from Wells Fargo
TipRanks News
Bearish
Piper Sandler Reaffirms Their Buy Rating on Revolution Medicines (RVMD)
TipRanks News
Neutral

News Score - Last 7 Days

Positive
RVMD
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RVMD’s Media Buzz Sentiment?
4 articles about RVMD were published this week. In an average week, 3.75 articles are published.
    What is RVMD’s weekly average amount of articles?
    In an average week, 3.75 articles about RVMD are published.
      What is RVMD’s News Sentiment?
      100% of articles about RVMD were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week